Literature DB >> 16572576

Does low-dose ASA help prevent cardiovascular events in women?

Abdullah Alkhenizan1, W Farooq.   

Abstract

Entities:  

Year:  2006        PMID： 16572576      PMCID： PMC1479715     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

1.  Should patients who have not had a cardiac event take ASA to prevent one?

Authors:  Abdullah Alkhenizan
Journal:  Can Fam Physician       Date:  2002-01       Impact factor: 3.275

Review 2.  Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.

Authors:  Carlo Patrono; Fedor Bachmann; Colin Baigent; Christopher Bode; Raffaele De Caterina; Bernard Charbonnier; Desmond Fitzgerald; Jack Hirsh; Steen Husted; Jan Kvasnicka; Gilles Montalescot; Luis Alberto García Rodríguez; Freek Verheugt; Jozef Vermylen; Lars Wallentin; Silvia G Priori; Maria Angeles Alonso Garcia; Jean Jacques Blanc; Andrzej Budaj; Martin Cowie; Veronica Dean; Jaap Deckers; Enrique Fernández Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; João Morais; Jaap Deckers; Rafael Ferreira; Gianfranco Mazzotta; Philippe Gabriel Steg; Frederico Teixeira; Robert Wilcox
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

3.  Medication therapy in ambulatory medical care. National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, 1992.

Authors:  C R Nelson; D E Knapp
Journal:  Adv Data       Date:  1997-08-08

4.  Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Hayden; Michael Pignone; Christopher Phillips; Cynthia Mulrow
Journal:  Ann Intern Med       Date:  2002-01-15       Impact factor: 25.391

5.  Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Authors:  P S Sanmuganathan; P Ghahramani; P R Jackson; E J Wallis; L E Ramsay
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

6.  Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke.

Authors:  T K Lee; Y C Chen; T L Kuo
Journal:  Thromb Res       Date:  1987-08-01       Impact factor: 3.944

7.  Systemic availability of acetylsalicylic acid in normal men and women and its effect on in vitro platelet aggregability.

Authors:  S E Husted; A K Pedersen; T Petersen; E Geday
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.